I'm interning at the spike
Release time:
2020-08-14
My internship at Peak
■ Intern Hu Cheng
is something every college student must go through before graduation, and so am I. Before I came to Jianfeng Health Technology Company for internship, I checked the information of Jianfeng from the Internet, and only then did I know that this is an enterprise involving many industries and with extensive influence. This made me very excited and uneasy, and worried that I could not do a good job. After all, what I learned in the school was some concepts, and the practical training was based on the textbooks, which would definitely be different from the actual work of the enterprise; there is also the problem of getting along with colleagues... In short, I think a lot. Because of this, I made preparations early and even took a taxi to find my way in advance for fear of being late on the first day. Who knows the company has a shuttle bus, this welfare is really good!
The first time I came to the company, I saw that my colleagues were very easy-going, which made me full of confidence. I made up my mind to get along well with my colleagues, learn more accounting knowledge and the truth of life, and lay the foundation for future accounting work.
In the first week of my internship, I didn't feel as difficult as I expected, because Zhou Jie just asked me to look through the previous bookkeeping vouchers and paste and arrange the bills to bind them into a book. Because it is not the same as the method in the school training class, I have done simple work for a long time. Zhou Jie also taught me how to bind the vouchers neatly and beautifully, which are all things that have not been touched in the school. Even so, I am a little annoyed and feel that it is useless to do these things. Later, I checked the entry "accounting internship to see vouchers" on the Internet, only to understand Zhou Jie's intention-to see vouchers is the basis of accounting learning, the real economic significance is in the attachment, even how to paste, how to correspond to entries are knowledge. I know I still have a lot to learn. Zhou Jie told me that if there are problems, first see how others can solve them. Don't just rely on others. This sentence I bear in mind.
The task of the second week is to read the previous account books and print the bound account books. This is my first time to use the page numbering machine. My colleague Xiaoya taught me how to use it and how to add ink. I will soon be handy. This week, I probably know the responsibilities of my colleagues. When I encounter problems, I can find someone to consult accurately.
In the third week, Zhou Jie said that I could learn the knowledge of invoicing. I watched Xiaoya do it again first and understood the points that need to be paid attention to in invoicing, such as tax number, commodity details, no ambiguity, no omission of remarks column, no wrong tax rate selection, etc. For each invoice issued, I have to carefully check these points before printing, then confirm the printing, then standardize the stamping and submit it for review. Therefore, the efficiency is not as good as Xiaoyagao, but I believe practice makes perfect. This week, I also helped to revise a document and changed it three times. I felt that my office software was not operating well. I was dizzy when I revised it for the third time. I suddenly got stuck and didn't know what I was doing. I didn't finish it until I got off work. in exchange, Zhou Jie said, "Xiao Hu, you are good." A short sentence made me very happy and in a super good mood after work.
During my internship, I longed for a new day and cherished the harvest every day. I know that internship is a stage of gradual understanding, familiarity and learning, and a repeated process of "practice - learning - practice. Although it has been less than a month, I have learned a lot and really feel that theory and practice are really different. These progress, let me very happy also has a sense of accomplishment. I thank my colleagues for their help. In the next few days, I will make persistent efforts to accumulate experience and knowledge wealth for the formal work position in the future.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page